Vinoperfect Serum for Hyperpigmentation
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is designed to evaluate the effectiveness and safety of Vinoperfect, a skin-brightening serum, for treating post-inflammatory hyperpigmentation (PIH), or dark spots that can develop after acne, in participants with Fitzpatrick Skin Types IV-VI (medium to deep skin tones). The study will assess Vinoperfect as part of a comprehensive skincare routine that includes cleansing, treatment, moisturization, and protection from sunlight.
Who Is on the Research Team?
Andrew Alexis, MD, MPH
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for people with medium to deep skin tones (Fitzpatrick types IV-VI) who have dark spots or discoloration after acne, including those with acne scars. Participants should not have other major skin conditions.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Vinoperfect brightening serum
Trial Overview
The study tests Vinoperfect brightening serum as part of a full skincare routine to see if it helps fade dark spots from acne in people with darker skin tones.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will undergo a standardized twice-daily skincare regimen for 12 weeks. In the morning, participants will cleanse their face, apply the Vinoperfect Brightening Serum, apply moisturizer, and then apply SPF 50+ sunscreen. In the evening, participants will cleanse their face, apply the Vinoperfect Brightening Serum, and apply moisturizer.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
Caudalie
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.